Gene: FASTKD2
Official Full Name: FAST kinase domains 2provided by HGNC
Gene Summary: This gene encodes a protein that is localized in the mitochondrial inner compartment and that may play a role in mitochondrial apoptosis. Nonsense mutations have been reported to result in cytochrome c oxidase deficiency. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30243 | FASTKD2 Knockout cell line (HeLa) | Human | FASTKD2 | 1:3~1:6 | Negative | Online Inquiry |
KO30244 | FASTKD2 Knockout cell line (HCT 116) | Human | FASTKD2 | 1:2~1:4 | Negative | Online Inquiry |
KO30245 | FASTKD2 Knockout cell line (HEK293) | Human | FASTKD2 | 1:3~1:6 | Negative | Online Inquiry |
KO30246 | FASTKD2 Knockout cell line (A549) | Human | FASTKD2 | 1:3~1:4 | Negative | Online Inquiry |
FASTKD2 Gene Knockout Cell Lines are specialized biological research tools designed to facilitate the study of gene function by enabling targeted disruption of the FASTKD2 gene. This gene plays a pivotal role in mitochondrial RNA metabolism and cellular energy regulation. The knockout cell lines are engineered using advanced CRISPR-Cas9 technology, which allows for precise genome editing. By creating a complete deletion of the FASTKD2 gene, researchers can investigate its biological implications, characterize associated cellular pathways, and assess the consequences of gene loss on mitochondrial dynamics and cellular metabolism.
The key function of FASTKD2 Gene Knockout Cell Lines lies in their ability to mimic conditions of gene inactivation, providing profound insights into mitochondrial functions, apoptosis regulation, and metabolic reprogramming in various physiological and pathological contexts. In research settings, these knockout cell lines are invaluable for elucidating disease mechanisms, particularly in cancer and metabolic disorders where mitochondrial dysfunction is often implicated.
One of the primary advantages of the FASTKD2 Gene Knockout Cell Lines compared to alternative gene knockout models is the robustness and reproducibility of the results, coupled with the ease of use inherent to the CRISPR-Cas9 system. Unlike traditional genetic knockout methods, which may induce off-target effects or require labor-intensive procedures, these engineered cell lines offer a streamlined approach for rapid experimentation and validation of hypotheses.
For researchers and clinicians, deploying FASTKD2 Gene Knockout Cell Lines can significantly accelerate the pace of discovery, enhancing the ability to model human diseases, test therapeutic strategies, and develop potential interventions. As a company dedicated to biotechnological innovation, we pride ourselves on providing high-quality genetic tools and resources that empower the scientific community to unlock new biological insights. Our expertise in gene editing technologies ensures that our products are not only effective but also reliable and tailored to meet the diverse needs of researchers in academia and industry alike.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.